Tag

Transgender Health

Study Explores Less Invasive Options For Transmasculine Sexual Health Screening

By | Education, Fenway Health Newsroom, Health Care, LGBT Health, Research, The Fenway Institute, Trans | No Comments
Female-to-male (FTM) transgender men and transmasculine individuals are people who are assigned female at birth but identify as male or as masculine. Many FTM transgender men and transmasculine individuals are born with reproductive organs typically labeled as female (e.g. cervix), and most FTM transgender men and transmasculine individuals do not choose to undergo a full hysterectomy (removal of the uterus, cervix, fallopian tubes, and ovaries).1 Because of this, many FTM and transmasculine people are at risk for cervical cancer, human papillomavirus (HPV), as well as other sexually transmitted infections (STIs) and may not realize it. It is recommended that anybody 
Read More

Registration Open For Fenway’s Third Annual Transgender Health Conference

By | Education, Fenway Health Newsroom, Fenway News, Health Care, The Fenway Institute, Trans | No Comments
Fenway Health invites you to join us for our annual “Advancing Excellence in Transgender Health” Conference from October 13 to 14, 2017. This year’s conference is being offered as a national course accredited by Harvard Medical School. Local and nationally-recognized experts will train the whole health care team in providing competent and confident gender-affirmative health care, grounded in research evidence and best clinical practices. The conference is produced by our team of medical, mental health, and health research experts. The conference program includes foundational material for all members of health care teams as well as specialized content for both medical 
Read More

The Fenway Institute Helps Develop Model Of HIV Care For Transgender Women In Peru

By | HIV/AIDS, Research, The Fenway Institute, Trans, Women's Health | No Comments
More than 100 transgender women in Lima, Peru, have joined an amfAR-funded study that aims to determine if combining HIV prevention and treatment with gender-affirming medical care will help these women access health services and remain in care. Transgender women have the highest prevalence of HIV in Peru—30 percent in Lima, according to one study, yet the least access to services. “Stigma and discrimination are powerful barriers that prevent transgender women from participating in society,” said principal investigator Dr. Javier Lama of Asociación Civil Impacta Salud y Educación (IMPACTA), a nonprofit that conducts HIV/AIDS research. “The staff of most public 
Read More

Edge Media Names Policy Brief On PrEP For Transgender Women As One Of Top Women’s Health Stories Of 2016

By | Fenway Health Newsroom, HIV/AIDS, Trans | No Comments
Edge Media Network has highlighted policy brief “Transgender women and pre-exposure prophylaxis for HIV prevention: What we know and what we still need to know” as one of the most important women’s health stories of 2016. The brief was released last winter by the National Center for Innovation in HIV Care—a program of The Fenway Institute, AIDS United, and ARCW. In it, researchers explored the interaction between feminizing hormones used by transgender women, and the medication currently approved for use as pre-exposure prophylaxis for HIV prevention (PrEP). The brief also brought attention to the urgent need for more lifesaving research 
Read More

Shortage of Injectable Estrogen is a Public Health Crisis

By | Fenway Health Newsroom, Trans | One Comment
For nearly two years, drug manufacturers have not been able to meet demand for injectable estrogen, which is a commonly prescribed hormone therapy for transgender women. A policy brief released today by The Fenway Institute, Callen-Lorde Community Health Center, and Treatment Action Group (TAG) describes the shortage as a “public health crisis” and urges the U.S. Food and Drug Administration (FDA) to be more proactive in seeking to resolve the crisis. “Hormone therapy is life-saving for many transgender individuals and the current shortage of injectable estrogen violates transgender individuals’ right to comprehensive medical treatment that is free of discrimination,” said 
Read More